Back
NSB
Neuroscientific Biopharmaceuticals Ltd
๐ฆ๐บ ASX
๐ Overview
๐ Performance
๐ต Cost
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
N/A
Annual Growth
5 years average annual capital growth
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
0
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Neuroscientific Biopharmaceuticals Ltd. engages in researching and developing novel peptide-based pharmaceutical products. The Companyโs product portfolio includes EmtinB, a therapeutic peptide initially targeting Alzheimerโs disease and glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn, and EmtinBn), which have demonstrated similar therapeutic potential as EmtinB. EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human bodyโs innate immune response to cell injury.
๐ Performance
Price History
-51.11%
1M
All Time
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$0.11
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in NSB
0
๐ Total Capital Earnings
N/A
๐ Average investment frequency
N/A
๐ต Average investment amount
N/A
โฐ Last time a customer invested in NSB
1414 days
NSB investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
๐ถ Age of investors
18 - 25
26 - 34
35 - 90
๐ Legal gender of investors
Female
Male
Pearlers who invest in NSB also invest in...
Lithium Australia Ltd. is an Australian based mineral exploration company. The company is headquartered in Perth, Western Australia. The company went IPO on 2007-10-30. The firm has two business divisions: Envirostream and VSPC. Envirostream is a battery recycling industry. VSPC is engaged in developing in cathode powders, including lithium ferro phosphate. Its operating segments include Battery Recycling, Battery Materials, Chemicals and Raw Materials. Its Battery Recycling segment is engaged in research and development of processing technology for mixed-battery recycling, as well as the sale of recovered energy metals. Its process involves recovery of energy metals as a mixed metal dust (MMD), which is then exported for refining. Its Battery Materials segment is engaged in research and development of battery materials including lithium ferro phosphate (LFP), as well as the sale of battery energy storage systems. Its Chemicals segment is engaged in research and development of a range of extraction and refining technologies.
๐ Share price
$0.04 AUD
Want more shares? Try these...